OMS721 is Expected to Receive Orphan Drug Status for Use in Hematopoietic Stem Cell Transplantation
nosheep / Pixabay

OMS721 is Expected to Receive Orphan Drug Status for Use in Hematopoietic Stem Cell Transplantation

According to a source article on Business Wire that can be found here, the Committee for Orphan Medicinal Products (part of the European Medicines Agency) has recommended that the experimental…

Continue Reading OMS721 is Expected to Receive Orphan Drug Status for Use in Hematopoietic Stem Cell Transplantation